Search results
Results From The WOW.Com Content Network
Aichi Medical University ja; Dokkyo University School of Medicine ja; Fukuoka University ja; Fujita Health University ja; Hyogo College of Medicine ja; Iwate Medical University ja; Jichi Medical School ja
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. [7] The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, the Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, and Genmab K.K. in Tokyo, Japan.
Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab. [9] Daratumumab was granted breakthrough therapy drug status in 2013, for multiple myeloma.
Also, each university or college is listed in the prefecture in which its headquarters is located, not the location of their satellite campuses, etc. or that of some of its departments or divisions. For the list of universities that existed in the past or merged into another school, see List of historical universities in Japan .
Newsweek's World's Best Hospitals 2023 ranks it 17th in the world, 2nd in Asia, and 1st in Japan. [2] Notably, it serves as the primary hospital for the Imperial Family of Japan, with both the current emperor and the emperor emeritus having undergone major operations there. [3] [4]
Gunma University was established in 1949 by integrating the national colleges in Gunma Prefecture: Maebashi College of Medical Science (前橋医科大学, Maebashi ika daigaku), Kiryu Technical College (桐生工業専門学校, Kiryū kōgyō semmon gakkō), Gunma Normal School (群馬師範学校, Gunma shihan gakkō) and Gunma Youth Normal School (群馬青年師範学校, Gunma seinen ...
Zalutumumab (proposed trade name HuMax-EGFR) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR). It is a product developed by Genmab in Utrecht, the Netherlands.
The National Defense Medical College (防衛医科大学校, Bōei Ika Daigakkō) is Japan's six-year university-level military academy under control of the Ministry of Defense whose objectives are to train future military officers who are also medical doctors and current military doctors. [1]